Company registration number 11843830 (England and Wales)
JLINKS PHYSIOTHERAPY LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024
PAGES FOR FILING WITH REGISTRAR
JLINKS PHYSIOTHERAPY LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
JLINKS PHYSIOTHERAPY LIMITED (REGISTERED NUMBER: 11843830)
BALANCE SHEET
AS AT
31 MARCH 2024
31 March 2024
- 1 -
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
3
2,426
3,319
Current assets
Debtors
4
8,883
11,939
Cash at bank and in hand
196,347
155,038
205,230
166,977
Creditors: amounts falling due within one year
5
(67,658)
(65,985)
Net current assets
137,572
100,992
Total assets less current liabilities
139,998
104,311
Provisions for liabilities
(572)
(830)
Net assets
139,426
103,481
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
139,326
103,381
Total equity
139,426
103,481

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 26 July 2024 and are signed on its behalf by:
Mrs J Steadman
Mrs J Ward
Director
Director
JLINKS PHYSIOTHERAPY LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024
- 2 -
1
Accounting policies
Company information

JLinks Physiotherapy Limited is a private company limited by shares incorporated in England and Wales. The registered office is 2nd Floor (Right) Downe House, 303 High Street, Orpington, Kent, England, BR6 0NN.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £1.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Turnover

Turnover is recognised at the fair value of consideration received or receivable for the services provided in the normal course of business, The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and equipment
25% on reducing balance
Computers
25% on straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.6
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

JLINKS PHYSIOTHERAPY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
1
Accounting policies
(Continued)
- 3 -
1.7
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
9
8
3
Tangible fixed assets
Plant and equipment
Computers
Total
£
£
£
Cost
At 1 April 2023
1,502
6,320
7,822
Additions
-
0
1,118
1,118
At 31 March 2024
1,502
7,438
8,940
Depreciation and impairment
At 1 April 2023
896
3,607
4,503
Depreciation charged in the year
151
1,860
2,011
At 31 March 2024
1,047
5,467
6,514
Carrying amount
At 31 March 2024
455
1,971
2,426
At 31 March 2023
606
2,713
3,319
4
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
7,122
9,690
Other debtors
1,761
2,249
8,883
11,939
JLINKS PHYSIOTHERAPY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
- 4 -
5
Creditors: amounts falling due within one year
2024
2023
£
£
Taxation and social security
34,200
28,513
Other creditors
33,458
37,472
67,658
65,985
2024-03-312023-04-01false26 July 2024CCH SoftwareCCH Accounts Production 2024.100No description of principal activityMrs J SteadmanMrs J Wardfalsefalse118438302023-04-012024-03-31118438302024-03-31118438302023-03-3111843830core:PlantMachinery2024-03-3111843830core:ComputerEquipment2024-03-3111843830core:PlantMachinery2023-03-3111843830core:ComputerEquipment2023-03-3111843830core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-3111843830core:CurrentFinancialInstrumentscore:WithinOneYear2023-03-3111843830core:CurrentFinancialInstruments2024-03-3111843830core:CurrentFinancialInstruments2023-03-3111843830core:ShareCapital2024-03-3111843830core:ShareCapital2023-03-3111843830core:RetainedEarningsAccumulatedLosses2024-03-3111843830core:RetainedEarningsAccumulatedLosses2023-03-3111843830bus:Director12023-04-012024-03-3111843830bus:Director22023-04-012024-03-3111843830core:PlantMachinery2023-04-012024-03-3111843830core:ComputerEquipment2023-04-012024-03-31118438302022-04-012023-03-3111843830core:PlantMachinery2023-03-3111843830core:ComputerEquipment2023-03-31118438302023-03-3111843830core:WithinOneYear2024-03-3111843830core:WithinOneYear2023-03-3111843830bus:PrivateLimitedCompanyLtd2023-04-012024-03-3111843830bus:SmallCompaniesRegimeForAccounts2023-04-012024-03-3111843830bus:FRS1022023-04-012024-03-3111843830bus:AuditExemptWithAccountantsReport2023-04-012024-03-3111843830bus:FullAccounts2023-04-012024-03-31xbrli:purexbrli:sharesiso4217:GBP